1-(1-Methyl-4-piperidinyl)piperazine - CAS 23995-88-2
Catalog: |
BB018279 |
Product Name: |
1-(1-Methyl-4-piperidinyl)piperazine |
CAS: |
23995-88-2 |
Synonyms: |
1-(1-methylpiperidin-4-yl)piperazine |
IUPAC Name: | 1-(1-methylpiperidin-4-yl)piperazine |
Description: | 1-(1-Methyl-4-piperidinyl)piperazine (CAS# 23995-88-2) is used in preparation of Pyrazolo Estratrienes as inhibitors of 17-HSD1. |
Molecular Weight: | 183.29 |
Molecular Formula: | C10H21N3 |
Canonical SMILES: | CN1CCC(CC1)N2CCNCC2 |
InChI: | InChI=1S/C10H21N3/c1-12-6-2-10(3-7-12)13-8-4-11-5-9-13/h10-11H,2-9H2,1H3 |
InChI Key: | OHUMKYGINIODOY-UHFFFAOYSA-N |
Boiling Point: | 260.3 °C at 760 mmHg |
Purity: | > 98 % |
Density: | 0.992 g/cm3 |
MDL: | MFCD01075186 |
LogP: | 0.19040 |
GHS Hazard Statement: | H314 (97.73%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] |
Precautionary Statement: | P260, P264, P280, P301+P330+P331, P303+P361+P353, P304+P340, P305+P351+P338, P310, P321, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113150058-A | Tripterine derivative and preparation method and application thereof | 20210423 |
CN-113024454-A | Synthesis method of brigatinib intermediate | 20210325 |
WO-2021127070-A1 | Intranasal pharmaceutical compositions of cgrp inhibitors | 20191217 |
KR-102267662-B1 | Benzamide derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer containing the same as an active ingredient | 20191119 |
KR-20210061489-A | Benzamide derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer containing the same as an active ingredient | 20191119 |
PMID | Publication Date | Title | Journal |
21290451 | 20110315 | Piperazines for peptide carboxyl group derivatization: effect of derivatization reagents and properties of peptides on signal enhancement in matrix-assisted laser desorption/ionization mass spectrometry | Rapid communications in mass spectrometry : RCM |
Complexity: | 146 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 183.173547683 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 183.173547683 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 18.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.2 |
-
Catalog: BB024422
(2S,6S)-2,6-Dimethylpiperazine
Detail
-
Catalog: BB028840
(2S,5R)-1-Boc-2,5-dimethylpiperazine
Detail
-
Catalog: BB018978
(3-Oxopiperazin-1-yl)acetic acid
Detail
-
Catalog: BB079235
(2R,5R)-tert-Butyl 5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate
Detail
-
Catalog: BB045251
(3,6-Dichlorobenzothiophen-2-yl)-piperazin-1-yl-methanone 2,2,2-trifluoroacetic acid
Detail
-
Catalog: BB078843
(2R,5R)-1,2,5-trimethylpiperazine dihydrochloride
Detail
-
Catalog: BB021304
(3S)-1-benzyl-3-(propan-2-yl)piperazine
Detail
-
Catalog: BB052624
(2-Fluorophenyl)-piperazin-1-ylmethanone 2,2,2-trifluoroacetic acid
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperazines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS